An intensive 2-day training course designed for professionals in Business Development, Licensing, and Strategic Partnerships. Learn from industry experts with 35+ years of deal-making experience.
Are you ready to unlock the secrets of successful deal making in the dynamic world of pharma and biotech? Join us for an intensive and practical 2-day course that will equip you with the essential skills and knowledge needed to navigate the complex landscape of licensing, partnerships, and negotiations.
At our course, you will learn from industry experts who have a deep understanding of the valuation approaches, risk assessment methodologies, and deal structuring techniques that are currently shaping the pharma-biotech world. We have carefully designed the agenda to cover all the crucial topics, ensuring that you leave with a comprehensive understanding of the deal-making process.
Our course offers a hands-on approach, providing you with practical tools, templates, and Excel-based valuation models that you can immediately apply in your professional endeavors.
Course leader Dimitri F Dimitriou, FRSM, has 35 years' experience and has been involved in over 200 deals. Gain invaluable insights from a true industry authority.
Engage with a diverse audience of executives from pharma, biotech, and related industries. Forge new connections and expand your professional network.
Unlock the power of deal making in the dynamic world of pharma and biotech. Master the strategies, skills, and frameworks essential for successful collaborations.
This condensed 2-day course offers a comprehensive overview of the key aspects of deal making in the pharma and biotech industry, including MedTech and Digital Health. Participants will gain valuable insights into the entire deal-making process, covering preparation, due diligence, licensing, IP protection, valuation, negotiation, and relationship management.
The course is designed to equip attendees with practical strategies, essential skills, and proven frameworks to execute successful collaborations and navigate complex partnership landscapes in the life sciences sector.
Dimitri has over 35 years' experience in the pharmaceutical and biotech industry. Over the last 20 years, he is the founder and Managing Director of DyoDelta Biosciences, an advisory company specializing in providing support in putting together corporate collaborations in the Life Sciences.
He has been involved in over 200 pharma/biotech agreements, mostly cross-border transactions and has been a speaker or chairman in 40 conferences. He is a co-founder and former CEO of ImmuPharma plc, a drug development biotech company listed on AIM of the London Stock Exchange.
Join industry professionals and transform your deal-making capabilities. Secure your place in this intensive 2-day training course led by one of the most experienced BD&L experts in the life sciences sector.